How GLP1 medications changed internet culture

Before any of it had a proper name, the internet started noticing the faces. A musician's cheekbones, suddenly sharper. An actress at an awards show, slimmer than she had been six months earlier. A talk-show host whose suits, season after season, hung differently. The captions on the photographs were polite. The comments were not. By the end of 2022, the question that the gossip pages and the algorithm had both steadily settled on was not whether a particular celebrity had lost weight. It was which drug they were on.

What followed was the fastest cultural rebrand of a medical class in living memory. A diabetes drug became a status symbol. A weekly injection became dinner-party content. A serious treatment for a serious condition became, somewhere between TikTok and the gossip columns, the most discussed pharmaceutical of the decade. The official name was semaglutide. The street name became Skinny Jabs. The polite name, in the rooms where people did not want to say what they were doing, became the O Word.

This is a closer look at how GLP1 medications steadily rewired the vocabulary, etiquette, and image grammar of the internet — and at what that change has revealed about the wider culture around bodies, status, and the new lines being drawn between vanity, health, and shame.

The quick answer

The celebrity tipping point

Drugs that steadily reshape bodies are not new. Plastic surgery has always been part of the celebrity economy, as has personal training, restrictive eating, and the careful management of the camera angle. What made GLP1 medications different was the speed and the visibility of the change, combined with the difficulty of denying it. A face cannot subtly slim by twenty percent in nine months without people noticing. The internet noticed.

The early phase was, by celebrity standards, almost charmingly chaotic. Some stars admitted to the medication and were celebrated for honesty. Some denied it convincingly. Some denied it unconvincingly. Some refused to comment, which the internet treated as confirmation. By the end of 2023, the question of whether a public figure was on a GLP1 had become as routine a piece of gossip as the question of who they were dating.

A small, important moment of cultural permission happened in the middle of this stretch. A prominent industry figure, asked at an event how he had lost so much weight, simply said the name of the drug. The world did not end. He kept working. The implicit message landed at scale: the medication did not have to be a secret anymore. From that point onwards, the conversation moved much faster, and much more openly, than it ever had with previous body-altering interventions.

The new vocabulary, and what it actually means

Every cultural moment generates its own dictionary. The GLP1 era produced a particularly inventive one, partly because the conversation moved across so many platforms, and partly because users, journalists, and creators needed shorthand for experiences that did not yet have polite words.

• Skinny Jab — the catch-all street term for any weekly GLP1 injection, used affectionately, sarcastically, and clinically depending on context.
• Skinny Pen — a slightly softer variant, often used by users who prefer to describe the device rather than the practice.
• The Hollywood Shot — the implicit, glamorous version of the above, with the understanding that the user has access, money, and a stylist.
• The O Word — Ozempic spoken without being spoken, the polite refusal-to-confirm at school gates, dinner parties, and television interviews.
• Food Noise — the constant background hum of food-related thoughts and cravings that GLP1 medications famously clear.
• Ozempic Face — the gaunt or hollow appearance some users develop, particularly with rapid loss in older patients with less facial fat to begin with.
• Ozempic Body — the slim, slightly soft-tissue-poor shape that the medication can produce without resistance training.
• Pen Day — the user's chosen day of the week for the injection, often referenced in dating apps, group chats, and TikTok content as a kind of weekly waypoint.

What these words share is a particular tone — half clinical, half cultural, almost always knowing. They are the language of a moment in which an entire society has been forced to admit that the body and the pharmaceutical are now part of the same conversation, and is figuring out how to talk about it.

TikTok, Instagram, and the visual grammar of the journey

On TikTok in particular, the GLP1 medication has produced an entire genre of content. Pen Day rituals. Side-effect updates. Honest weekly weigh-ins. The slow, almost confessional comparison videos that show a face nine months apart. Recipes for tiny, satisfying meals. Sleeping tips. Hydration tips. Calls and responses about the worst days and the easiest days. The medication, in its first three years, became one of the most documented private experiences in social-media history.

Instagram, true to its older instincts, produced a different version. Glossier. More curated. Less honest. The Hollywood-aesthetic post, the perfectly plated protein breakfast, the morning-light selfie that elegantly skips over the difficult parts. Both versions are real. Both are doing different cultural work. Both have shaped, in their separate ways, what users coming to the medication now expect to feel and see.

The most interesting effect of all of this is the speed at which information now travels. A new side effect mentioned by one creator can be discussed by ten thousand others by the end of the week. A genuinely useful tip — a way to ease nausea, a hydration trick, a particular brand of high-protein yoghurt — can spread across a continent in days. The collective intelligence of a million private journeys has, in a strange way, made the medication easier to live with.

The new celebrity aesthetic, and the clear death of the old one

The faces that defined the early-2020s film and music industries were noticeably different from the faces that defined the early-2010s. The cheekbones became more visible. The jawlines became sharper. The bodies became thinner in a particular way — less athletic, more sculptural, with the soft contours of the cheek pulled in. The visual grammar of the red carpet shifted in a way that, in retrospect, could not have been produced by diet and pilates alone.

Some users of the medication welcomed the new aesthetic. Some pushed back against it. A cultural argument steadily developed about whether GLP1 medications were collapsing the diversity of body types that pop culture had spent a decade slowly expanding. The argument is unresolved, and likely to remain so. What is clear is that the visual default of the celebrity world shifted, and that the shift had a real biological cause underneath it.

The interesting question, in the longer run, is what happens as the medication becomes ordinary rather than exceptional. The celebrity Hollywood Shot is, increasingly, a routine prescription in suburbs across multiple countries. The aesthetic that briefly belonged to a few thousand people on red carpets is becoming the body of millions. At that point, it stops being an aesthetic at all, and starts being demographics.

The clear end of the shame economy

Before GLP1 medications, the cultural conversation about weight loss in public was almost entirely built around shame. Diet programmes promised to make people work for their bodies. Magazines celebrated the bikini moment. Social media weight-loss content was largely framed as a triumph of discipline. The implicit message — that being larger was a moral failure to be redeemed through effort — was rarely stated openly, but was deeply present.

GLP1 medications steadily punctured that frame. If the difference between a body that struggled with weight for thirty years and a body that did not is, in the end, a once-weekly injection, then the moral story about willpower and discipline becomes much harder to sustain. The conversation has moved, in the last three years, toward something more honest: that obesity is a biological condition with biological treatments, and that the previous shame around it was, like a lot of moral panics, doing more cultural work than medical work.

Not everyone has welcomed this shift. There is a real and respectable wellness tradition that argues for habits, food quality, sleep, and movement as the foundations of health, and that worries about a pharmaceutical answer to what is also a societal question. There is a real argument about access, equity, and who gets to benefit from the new medications first. There is a real concern about disordered eating, weight stigma, and the ways the medication can be used by people who would have been better served by other support. These arguments deserve to keep being made.

What has changed is the baseline. The previous baseline was that obesity was a personal failure. The new baseline, increasingly, is that it is a medical condition. Whatever happens next, that change in the conversation is not likely to be reversed.

Do GLP1 medications change personality or mood? →

Health culture absorbs the medication

Health culture, ever resourceful, did not fight the GLP1 era for long. By the second year of the public conversation, the medication had been steadily absorbed into the luxury wellness frame — alongside cold plunges, infrared saunas, longevity supplements, and the latest sleep-tracking ring. Telehealth start-ups offered concierge prescribing. Clinics offered the medication as part of a broader optimisation programme. The Hollywood Shot found a natural home in a culture that had already accepted the idea that the body was a project.

This absorption is not all bad. Many users have found genuinely good care through these channels. The medication itself works, regardless of the surrounding aesthetic. The risk, however, is that the framing — sleek, premium, transformative — can steadily obscure the fact that this is a serious medication with real side effects, real costs, and real questions about long-term use. The luxury wrapper does not change the biology underneath.

The meme layer

Every cultural moment is digested through humour, and the GLP1 era has produced a particularly sharp meme economy. The Ozempic-coded outfit. The Skinny Jab Friday meme. The very specific brand of joke about going to a restaurant and eating two bites of a starter. The collective acknowledgment, in a half-amused half-stunned way, that something genuinely strange has happened to how the world eats.

Memes are how a culture processes change. The willingness to joke about the medication is itself a sign of how thoroughly it has been absorbed into ordinary life. Diabetes drugs did not used to get punchlines. They do now. The punchlines are not always kind. They are, however, evidence that the medication is no longer an exotic news story; it is part of the cultural water supply.

What this actually means

The deeper change underneath the vocabulary and the memes is more important than any of the surface noise. The GLP1 era has, steadily and quickly, normalised the idea that a body that has struggled with weight for decades can change meaningfully with medical help, and that this kind of change does not have to be hidden, denied, or framed as a moral triumph. That is a real shift in how society thinks about bodies.

It is also, more steadily, a shift in how individuals think about themselves. A generation of users has been given measurable evidence that their previous struggles with food were not, primarily, a failure of character. That evidence is hard to give back. Whatever happens with future generations of these medications, the conversation about willpower, discipline, and the moral weight of body size has been changed in a way that will be hard to undo.

The next GLP1 revolution: oral pills →

Track your own journey, not the feed

Start your weekly check-ins →

Final reflection

The internet that the GLP1 era produced is a strange and revealing thing. A pharmacy queue has become a place to be seen. A weekly injection has become a piece of content. A cultural conversation about bodies that had been frozen for years has been suddenly and substantially unblocked. None of this was planned. None of it was particularly elegant. It is, however, real, and it is not going back to how it was.

Underneath the vocabulary and the memes and the celebrity speculation, what the GLP1 era has done is make a private experience publicly discussable. Millions of people who would once have struggled in silence now have a language, a community, and a clear permission to take their body's behaviour seriously as a medical question rather than a moral one. That is the part worth keeping when the rest of the noise fades — and it almost certainly will.

Track your journey with GLP1 Journal →